| Product Code: ETC8281876 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Large Molecule Drug Substance CDMO Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Large Molecule Drug Substance CDMO Market Revenues & Volume, 2021 & 2031F |
3.3 Mexico Large Molecule Drug Substance CDMO Market - Industry Life Cycle |
3.4 Mexico Large Molecule Drug Substance CDMO Market - Porter's Five Forces |
3.5 Mexico Large Molecule Drug Substance CDMO Market Revenues & Volume Share, By Service, 2021 & 2031F |
3.6 Mexico Large Molecule Drug Substance CDMO Market Revenues & Volume Share, By Source, 2021 & 2031F |
3.7 Mexico Large Molecule Drug Substance CDMO Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 Mexico Large Molecule Drug Substance CDMO Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for large molecule drugs in Mexico |
4.2.2 Growing trend of outsourcing drug substance manufacturing to CDMOs |
4.2.3 Favorable regulatory environment supporting the development of the CDMO market in Mexico |
4.3 Market Restraints |
4.3.1 Intense competition among CDMOs leading to pricing pressures |
4.3.2 Challenges in maintaining quality standards and compliance with regulations |
5 Mexico Large Molecule Drug Substance CDMO Market Trends |
6 Mexico Large Molecule Drug Substance CDMO Market, By Types |
6.1 Mexico Large Molecule Drug Substance CDMO Market, By Service |
6.1.1 Overview and Analysis |
6.1.2 Mexico Large Molecule Drug Substance CDMO Market Revenues & Volume, By Service, 2021- 2031F |
6.1.3 Mexico Large Molecule Drug Substance CDMO Market Revenues & Volume, By Contract Manufacturing, 2021- 2031F |
6.1.4 Mexico Large Molecule Drug Substance CDMO Market Revenues & Volume, By Clinical, 2021- 2031F |
6.1.5 Mexico Large Molecule Drug Substance CDMO Market Revenues & Volume, By Commercial, 2021- 2031F |
6.1.6 Mexico Large Molecule Drug Substance CDMO Market Revenues & Volume, By Contract Development, 2021- 2031F |
6.1.7 Mexico Large Molecule Drug Substance CDMO Market Revenues & Volume, By Cell Line Development, 2021- 2031F |
6.1.8 Mexico Large Molecule Drug Substance CDMO Market Revenues & Volume, By Process Development, 2021- 2031F |
6.2 Mexico Large Molecule Drug Substance CDMO Market, By Source |
6.2.1 Overview and Analysis |
6.2.2 Mexico Large Molecule Drug Substance CDMO Market Revenues & Volume, By Mammalian, 2021- 2031F |
6.2.3 Mexico Large Molecule Drug Substance CDMO Market Revenues & Volume, By Microbial, 2021- 2031F |
6.2.4 Mexico Large Molecule Drug Substance CDMO Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Mexico Large Molecule Drug Substance CDMO Market, By End-user |
6.3.1 Overview and Analysis |
6.3.2 Mexico Large Molecule Drug Substance CDMO Market Revenues & Volume, By Biotech Companies, 2021- 2031F |
6.3.3 Mexico Large Molecule Drug Substance CDMO Market Revenues & Volume, By CRO, 2021- 2031F |
6.3.4 Mexico Large Molecule Drug Substance CDMO Market Revenues & Volume, By Others, 2021- 2031F |
7 Mexico Large Molecule Drug Substance CDMO Market Import-Export Trade Statistics |
7.1 Mexico Large Molecule Drug Substance CDMO Market Export to Major Countries |
7.2 Mexico Large Molecule Drug Substance CDMO Market Imports from Major Countries |
8 Mexico Large Molecule Drug Substance CDMO Market Key Performance Indicators |
8.1 Capacity utilization rate of CDMOs in Mexico |
8.2 Number of new partnerships and collaborations between pharmaceutical companies and CDMOs |
8.3 Investment in research and development by CDMOs for process improvement and innovation |
8.4 Number of regulatory approvals obtained by CDMOs for manufacturing large molecule drug substances |
8.5 Customer satisfaction levels with the services provided by CDMOs in Mexico |
9 Mexico Large Molecule Drug Substance CDMO Market - Opportunity Assessment |
9.1 Mexico Large Molecule Drug Substance CDMO Market Opportunity Assessment, By Service, 2021 & 2031F |
9.2 Mexico Large Molecule Drug Substance CDMO Market Opportunity Assessment, By Source, 2021 & 2031F |
9.3 Mexico Large Molecule Drug Substance CDMO Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 Mexico Large Molecule Drug Substance CDMO Market - Competitive Landscape |
10.1 Mexico Large Molecule Drug Substance CDMO Market Revenue Share, By Companies, 2024 |
10.2 Mexico Large Molecule Drug Substance CDMO Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |